PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.98%
Negative net income growth while CRVO stands at 33.22%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
22.78%
D&A growth of 22.78% while CRVO is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
No Data
No Data available this quarter, please select a different quarter.
128.24%
SBC growth of 128.24% while CRVO is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-92.68%
Both reduce yoy usage, with CRVO at -4.30%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
314.60%
AP growth well above CRVO's 44.56%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
26.98%
Some yoy usage while CRVO is negative at -52.70%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-101.99%
Both negative yoy, with CRVO at -49.13%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-120.47%
Negative yoy CFO while CRVO is 31.15%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
72.96%
CapEx growth of 72.96% while CRVO is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
72.96%
Lower net investing outflow yoy vs. CRVO's 3260.26%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
86.96%
Debt repayment growth of 86.96% while CRVO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-90.54%
Negative yoy issuance while CRVO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.